Company presentation

Company Presentation 2008 www.walmark.biz

WALMARK • HEALTH FOR THE WHOLE FAMILY

Editorial

Editorial

The company Walmark is almost closing the 2nd de-

Thanks to extensive investments into technology, management systems and the knowledge of our employees we

cade of its presence on the market. In spite of the fact

have built up one of the most modern pharmaceutical plants in the Czech Republic, complying with GMP (Good

that Walmark began as a company with a wide range of

Manufacturing Practice) standards for the manufacture and distribution of nutritional supplements and pharmaceu-

business activities, over the long term we have become

ticals. Aside from nutritional supplements, which represent still the focal point of our turnover, we have also been

convinced of the correctness of our strategic orientation

established as a manufacturer of pharmaceutical product range since autumn 2004.

towards the field of pharmacy and healthy lifestyle. Consequently, we gradually abandoned our other unrelated

In addition to our leading market position in Czech Republic, we cover the region of Central and Eastern Europe

branches of business and at present we are focusing

by our quickly developing and expanding subsidiaries in another eight European countries (Slovakia, Poland, Hun-

fully on the development of nutritional supplements and

gary, Romania, Bulgaria, Ukraine, Lithuania and Latvia). Moreover, we export to other more than 20 countries in the

pharmaceuticals.

world.

Thanks to conceptual market-orientated focus and growing shares on Czech and other markets we have recently achieved our strategic target defined in the year 2001 to become the leading manufacturer of nutritional supplements in the region of Central and Eastern Europe by the year 2007.

The history of Walmark up to now is proof of the fact that under coequal conditions a company can be established “green-field” without foreign know-how and with minimum capital, and be successful in expanding in a demanding branch of business such as pharmaceutical production and to compete with the significant players on the entire Central European region.

The success of Walmark is a result of the joint efforts of all our employees. We are aware that success does not usually happen by itself, but it is founded on self-discipline, hard work and of course the necessary amount of luck.

Moreover, we have to emphasize that significant and integral part of this success are our business partners and satisfied customers around the world. It’s good to know that even in today’s globalised world, it’s possible to achieve this success and this knowledge inspires us and is a challenge for further work.

2

Walmar k

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

3

Company history and profile

The company Walmark, originally family company, was established in 1990. After the initial activities in the field of foreign trade with various commercial goods, in the first half of 1991, the company re-orientated its business activities to

Company history and profile

dealing with agricultural products, especially to export of special seeds for food production purposes.

Since the second half of 1991 the company started to develop business activities in the segment of non-alcoholic beverages, and one year later also in the field of pharmaceutical and para-pharmaceutical preparations, mainly nutritional supplements and cosmetics products. The three major scopes of mentioned business fields – trading with agricultural products, production and distribution of non-alcoholic beverages and production, import and distribution of pharmaceutical preparations represented the fundamental organizational structure of the company till September 2001.

At that time the management of the company took the decision to change the strategic orientation of the company towards the pharmaceutical business as a field with a high global perspective not only on Czech market but generally on the world market. In connection with this decision the Agricultural Products Division was sold as of the 1st October 2001 and the Food Division was sold as of the 1st January 2005.

The acquired resources were significantly invested by the company in the development of its Pharmaceutical Division. A brand new pharmaceutical plant complying with the GMP and belonging to the most modern in the Czech Republic has been built. Walmark was continuously gaining leading positions on the nutritional supplements market on the domestic as well as foreign markets where it performs its business activities through its own subsidiaries or local distributors.

In addition to nutritional supplements that are the primary source of the company’s turnover, WALMARK has also started the production of medicines since 2004. The original portfolio of nutritional supplements, that counts now some 90 products and is continually improved and enlarged, remains the core of the company’s sales was thus enriched by human medicines. The first medicine released on the market was the licensed over-the-counter preparation Septofort.

In these days the portfolio of medicines has been enlarged and already counts 5 products.

Besides the above mentioned investments, the company Walmark has focused also on strategic acquisitions in past years. The first acquisition was the successful purchase of the Proenzi trademark of joint nutrition in 2004 followed by the acquisition of the company Profitness, engaged in retail network of Vitaland shops, at the beginning of 2005 and by majority share purchase of the company Aminostar, the producer of sports nutrition and nutritional supplements for athletes, in 2006.

4

Walmar k

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

5

Milestones in the company history

Agricultural Products Division

1990

Commencement of trading with agricultural products

1992

Acquirement of the leading position in the trade with

2001

1993

Milestones in the company history

Milestones in the company history

Milestones in the company history

Pharmaceutical Division

Nature’s Bounty vitamin products – commencement of import and distribution

blue poppy seeds on the Czech market

1992

Slovakia – establishment of the branch office

Sale of the Agricultural Products Division

1994

Nutritional supplements under the Walmark brand – commencement of production and distribution

1996

Czech Republic – acquirement of the leading position on the nutritional supplements segment

Food Division

Export department – establishment and commencement of 1992

1995

Commencement of the production of carbonated

business activities and progressive expansion on foreign markets

soft drinks under the Walmark brand

Lithuania – entry on the market

Acquirement of the leading position among

1997

local producers of carbonated soft

1996

Bulgaria and Macedonia – entry on the market

drinks in the Czech Republic

1998

Latvia – entry on the market

Commencement of the production of fruit

1999

Poland – establishment of branch office

juices under the Relax brand 1997

2004

Romania – establishment of branch office

Estonia – entry on the market

Acquirement of the leading position

2000

Cyprus – entry on the market

among local producers of fruit juices in

2001

Production plant – expansion and modernization

the Czech Republic

Company transformation – transformation from

Sale of the Food Division

the liability limited company to Joint Stock Company

Kazakhstan – entry on the market

2003

Hungary – establishment of branch office

office

GMP standards - certification of the

Aminostar – purchase of majority

Pharmaceutical Division production

share of the company producing sports

Ukraine – establishment of branch office

nutrition and nutritional supplements

Proenzi – acquisition of trademark of joint

for athletes

nutrition products

Bosnia and Herzegovina,

Armenia – entry on the market

Slovenia, Croatia and Greece

Certificate of Good Manufacturing

– entry on the market

2004

2005

Practise – acquirement of the certificate

6

Walmar k

Bulgaria – establishment of branch

2002

2006

2007

Latvia – establishment of branch office

for manufacturing medicinal products

Turkey – entry on the market

Lithuania – establishment of branch

Superbrand – acquirement of

office

Superbrand status in Czech Republic

Serbia, France, Belarus, Azerbaijan

Achieving strategic target – leading

and Kuwait – entry on the market

manufacturer of nutritional supplements

Profitness – acquisition of the company

in the region of Central and Eastern

and its retail chain of 60 health shops Vitaland

Europe

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

7

mil. EUR

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

Consolidated turnover of Walmark holding

50,4

60,8

70,3

80,2

83,7

88,3

96,3

72,7

88,4

99,4

Turnover of Walmark, a.s. (CZE)

43,5

46,8

50,6

59,7

60,1

61,4

64,3

31,6

35,8

29,6

Number of employees of Walmark holding

430

567

702

778

878

905

979

846

902

1016

Number of employees of Walmark, a.s. (CZE)

311

327

380

418

485

535

566

416

418

447

Note:

Walmark company rating and awards

Basic economic indicators

Basic economic indicators

The financial data were converted from CZK to EUR by average yearly exchange rate between those two currencies in respective years The Agricultural Products Dvision was sold as of the 1st October 2001 The Food Division was sold as of the 1st January 2005 The data for 2007 are preliminary without approval of final accounts

Turnover of Walmark, a.s. (CZE) and consolidated turnover of Walmark holding

Walmark company rating and awards Since 2002, WALMARK, a.s. has undergone a procedure of regular rating of its effectiveness and financial health by the renowned rating agency CRA, which has been a part of the world rating agency

Moody’s Investors Service since

January 2006. WALMARK does this to improve the credibility and transparency of its current and potential financial and business partners and the entire professional public.

In 2005, after thorough analysis of the company’s results and assessing the perspectives of its future economy, CRA improved the long-term international rating of WALMARK, a.s. by one level, from Baa- to Baa. In its assessment, the agency considered the change of Walmark’s business caused by the sale of a significant part of the assets of the Food Division at the end of 2004 and by the decision to concentrate fully on the area of nutritional supplements and medicines. The results of the CRA rating analysis gave high scores to the successful cash-flow management and the financial stability of Walmark in the continuing increase of effectiveness, market position and knowledge of trademarks supported by active marketing, the quality of the product portfolio and in particular, the longstanding success in extending its foreign activities.

Number of employees of Walmark, a.s. (CZE) and Walmark holding

On the basis of the last rating assessment performed in August 2006 the company Walmark received from the world rating agency the grade A3.cz with the stable prospect according to the new Moody´s National rating.

Since 2003, Walmark has held a GMP (Good Manufacturing Practice) certificate and has complied with the requirements of the Drug Act and the GMP regulation for the production and distribution of medicines in the Czech Republic. It has proved the functionality of the established system of Good Manufacturing Practice (GMP) and, based on a successfully managed certification process and a permit issued by the State Institute for Drug Control, it has produced medicines since 2004.

In 2007, Walmark was awarded Superbrand status in Czech Republic. The foremost marketing, advertising and professional media experts ranked Walmark among 100 most prominent brands of the Czech Republic. More than 2000 brands struggled for membership within this exclusive group of 100 brands of the Czech Republic.

8

Walmar k

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

9

Organizational structure of the company

Pharmaceutical Division

Pharmaceutical Division

Organizational structure of the company

Thanks to extensive investments into technologies, control systems and employee knowledge, the company has one of the most modern pharmaceutical plants in the Czech Republic complying with the GMP (Good Manufacturing Practice) standards and it holds a permit for the production and distribution of pharmaceuticals. In addition to nutritional supple-

Board of Directors

ments, which represents still the focal point of the company turnover and counts some 90 products today, since autumn 2004 WALMARK has been also producing medicines. The ďŹ rst medicine released on the market was Septofort. This overStrategic Department

the-counter registered medicine has become the bestselling product for sore throats in the Czech Republic. In these

Executive Manager

Strategic Marketing

days the portfolio of medicines has been enlarged and already counts 5 products.

The company is thoroughly monitoring all business, marketing and legislative trends in the pharmaceutical ďŹ eld. FollowDrugs

Production & Logistics

Quality Control & Assurance

International Marketing

ing the continuous harmonization with the EU legislation, the Research & Development and Registration Department has been successfully participating in the approval process of new sources of vitamins and minerals for nutritional supplements. This process is another step towards increasing the quality and safety of nutritional supplements.

Fi & IT Finance

H R Human Resources

M di l Di t Medical Director

Recently new development laboratory has come into operation in Walmark. The new development laboratory complies with the standards of GMP and its equipment corresponds to the technological equipment of a self-contained producE po t Export

W l k Czech C hR bli Walmark Republic

Sales S l sC Coordinator di to

tion plant, naturally with a lower capacity corresponding to the size of the development and pilot batches, which makes the transfer of new products from the development into the routine manufacturing process considerably easier. The new laboratory will help to shorten and make the development process of new products more efďŹ cient and it will also serve

Walmark Slovakia

W l k Poland P l d Walmark

Business Development

during the testing of alternative raw materials suppliers for the existing products as the continuous tinuo assortment innovation and introducing new products on the market is one of the

Walmark Romania

Walmark Hungary

Aminostar

key ke factors for maintaining the leading position on the market.

Within the business strategy, the company has been continuously building prospecWalmark Ukraine

Walmark Bulgaria

Vitaland Vit l d

tive brands in different segments of nutritional supplements in order to meet the needs of its customers. It relies on creative and effective media campaigns using TV commercials, professional and regular press, PR activities and other alternative com-

Walmark Lithuatia

Walmark Latvia

Vitaland Czech Republic

munication tools in order to assure the awareness of both general and professional public. The effectiveness of these campaigns had a positive effect on achieving the planned p market shares, the reinforcing the brand position on the market and the sup-

V l d Slovakia Sl k Vitaland

po port of brands awareness.

Vitaland Pola Poland

10

Walmar k

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

11

Worldwide business and marketing activities of Walmark holding Parent company:

Subsidiary companies:

Czech Republic

Slovakia

Romania

Poland

Bulgaria

Hungary

Ukraine

Worldwide business and marketing activities of Walmark holding

Turnover development of the Pharmaceutical Division

Turnover development of the Pharmaceutical Division

Lithuania mil. EUR

2002

2003

2004

2005

2006

2007

Turnover of the Pharmaceutical Division of Walmark holding

30,8

35,9

49,2

67,5

82,7

86,2

Turnover of the Pharmaceutical Division of Walmark, a.s. (CZE)

15,3

17,7

23,3

30,1

35,4

26,0

Turnover of the Pharmaceutical Division of Walmark on foreign markets*

15,5

18,2

25,9

37,4

47,3

60,2

Latvia

* Foreign markets represent subsidiary as well as other export markets

Albania

Export markets:

Estonia

Montenegro

Kazakhstan

Russia

FYROM (Macedonia)

Azerbaijan

Belarus

France

Armenia

Austria

Portugal

Turkey

Slovenia

Greece

Jordan

Croatia

Cyprus

Kuwait

Bosnia and Herzegovina

Albania

United Arab Emirates

Serbia

12

Walmar k

Asia

Europe

Vietnam

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

13

Structure of the Walmark holding

CZECH REPUBLIC

SLOVAKIA

UKRAINE

LITHUANIA

Parent company Walmark, a.s. – Třinec Established in 1990

Subsidiary company Walmark, spol. s r.o. – Žilina Established in 1992

Subsidiary company Walmark, o.o.o. – Kiev Established in 2004

Subsidiary company Walmark, UAB – Vilnius Established in 2005

Turnover of the Pharmaceutical Division of Walmark, a.s. (CZE)

Structure of the Walmark holding

Structure of the Walmark holding

Structure of the Walmark holding

Turnover of the Pharmaceutical Division of Walmark Slovakia

ROMANIA R

POLAND

BULGARIA

LATVIA

S Subsidiary company Walmark Romania, S.R.L. – Bucharest W Established in 1997

Subsidiary company Walmark, Sp. z o.o. – Sosnowiec Established in 1999

Subsidiary company Walmark Bulgaria, EOOD – Sofia Established in 2006

Subsidiary company Walmark, SIA – Riga Established in 2007

HUNGARY H

EXPORT

S Subsidiary company Walmark, Kft. – Miskolc W Established in 2003

Export department Walmark, a.s. – Třinec Established in 1996

Parent company Subsidiary companies Export markets

14

Walmar k

C O M P A N Y P R E S E N TA TAT TION 2008

15

Products

In addition to a strong market position on domestic Czech market and quickly expanding anding sub-

The Walmark product portfolio counts around 90 preparations and consists of a wide range of products, from single-

sidiary companies in another eight European countries (Slovakia, Poland, Hungary, Roma-

component to specially designed and developed combination preparations and multi-component preparations. The aim

ng to nia, Bulgaria, Ukraine, Lithuania and Latvia) Walmark has been successfully exporting

of such a wide portfolio is the maximum effort to satisfy the needs of our customers at various target groups.

Products

Export Department

Export Department

another more than 20 countries worldwide. At present Walmark is the market leader in the segment of nutritional supplements in Czech Republic, Slovakia, Romania and Bul--

In all phases of the development of new products and innovations, the latest scientific knowledge and the experience of

garia. In other subsidiary countries – Poland, Hungary and Lithuania it ranks among

top experts from the Czech Republic and from abroad are used. Another source of information of no less importance is

the top 3 nutritional supplements producers on the market. However the company

the regular marketing researches carried out among customers.

is successfully challenging the competition in other markets as well and building its strong position there.

Continual renewing of product portfolio and launching new preparations on the market contributes to improvement of lives of the customers and to help them to solve their problems. The use of top-quality raw materials in connection with the high

n Thanks to large investments into marketing communication, Walmark is successful in

level of the production process is a guarantee of the high quality of all final products.

ular establishing brands that have leading position in individual segments. The most popular

For further information about the particular products please see the product catalogue.

brands on foreign markets include ArthroStop, Prostenal, GinkoPrim, Martians, Urinal,, Calmacin and others.

Vitamins, minerals, trace elements and natural products under the Walmark, Naturline and Nature’s Bounty brands

The main goal of the Walmark Export Department is searching for business opportunities worldwide for successful

Herbal extracts

launching of Walmark products and realizing business activities in countries where Walmark subsi-diaries are not pre-

Ginkgo Biloba, GinkoPrim, Korean Ginseng, Echinacea, Yucca

sented.There are systematically developed business activities in the countries of Central and Eastern Europe – namely in the former Soviet Union countries (Estonia, Russia, Belarus, Kazakhstan, Armenia, Azerbaijan) and in former Yugo-

Special range of preparations for specific health problems

slavia countries (Slovenia, Croatia, Serbia, Bosnia and Herzegovina, Montenegro, Macedonia).

Peaceful and harmonious life – Benosen®, GinkoStim, MemoPlus, Denoxinal® Quality and comfort life – Imunactiv™, Vitavision, Dialevel, Urinal, Salutil

After Cyprus, where Walmark has been selling its products for eight years, in 2005 France became another country

Women´s health and beauty – Mabelle®, Pregnium, Viaderm, Viaredin, Varixinal®

outside the group of former post-socialist countries where the company has been building a strong selling team. In

Attractive and beautiful appearance – CLA Clarinol™, Betabronz, Chromdiet

the second half of 00’, the company has been intensifying its business activities in another EU countries and has been

Healthy and active men – Prostenal®, Permen®

building its position namely in Portugal, Greece and Austria.

Full life at an advanced age - Vialong

With regards to destinations outside Europe, Walmark has entered successfully markets of Turkey, Kuwait, Jordan,

Multivitamins and multiminerals for adults Spectrum

United Arab Emirates and Vietnam with the purpose of building up a long-term business activities on those market and gradually to enter also other markets in the region of Middle East, Asia, etc. The international character of Walmark

Preparations for children

holding is confirmed by the fact that the ratio of sales realized in foreign markets in the total consolidated sales of the

Martians, EchinaBears, Dinos

holding first exceeded the level of 50% in 2005.

Joint nutrition ArthroStop®, Proenzi

Medications Septofort

16

Walmar k

C O M P A N Y P R E S E N TA TAT TION 2008

17

Production quality Production quality

Quality control

The company Walmark has fulfilled the requirements of the Drug Act and the GMP De-

Quality control affects all levels of material flow (processing) - receiving inspections of raw materials, continuous and inter-

cree for the Manufacture and Distribution of Pharmaceuticals in the Czech Repub-

operational inspections of semi-finished products, continuous manufacturing and receiving inspections of products all

lic and has proven the functionality of the established (GMP) Good Manufactur-

take place. If the material does not meet the quality requirements it is not released for processing or distribution. Regular

ing Practise system. Good Manufacturing Practice is a set of rules, which are

Production quality

Production quality

inspections of production and storage conditions also take place.

binding for pharmaceutical companies. A pharmaceutical company must ensure that the course of manufacture and all connected processes take

Quality assurance

place according to these rules, which guarantee the manufacture of

Quality guarantee is a set of system activities for ensuring the manufacture of top-quality products. It includes the estab-

top-quality, effective and safe pharmaceuticals. Walmark has been the

lishment of quality requirements for all raw materials, semi-finished products and products, requirements placed on equip-

holder of a permit for the manufacture of pharmaceuticals since 2003.

ment, manufacturing and storage areas, establishment of manufacturing and inspection procedures, ensure employee training and perform investigations within the scope of customer claims and discovered inconsistencies. The system of

Walmark has been regularly investing a significant amount of money to

internal inspections verifies both the individual processes and the functionality of the entire quality management system.

new production and development technologies, control system and exten-

The internal inspections are focused on conformation with all procedures, instructions, record-keeping and other activities,

sion of the existing quality control mechanisms. Recently the manufacturing

which are connected with purchase, inspection, manufacturing and storage. The Walmark company also makes use of

plant has been extended by a fluid granulation mechanism. It is a new technol-

regular quality audits by an independent party, this being a renowned company concerned with establishing and improv-

ogy for the manufacturing of tablets that contributes to the possibility of manu-

ing GMP systems, consulting and quality audits specialising in GMP requirements.

facturing tablets which are technologically more exacting, raw materials saving and the increase of the quality of the existing tablets on the basis of a better homogeneity of

Document management system (DMS)

the mixture.

The implementation of the new control systems in Walmark will secure the flawless quality of all processes and eliminate human errors. It is the system for the electronic document management (DMS = Document management system) and

Walmark quality management system

the computer system for the inventory control on the basis of EAN codes. The first system is designed especially for the

Production in the Walmark company takes place in compliance with all the legislative requirements that are placed on

maintenance and updating of registration and regulation documentation. The other system will contribute to the elimination

the individual types of manufactured products; this concerns in particular the Food Act, the Drug Act and other related

of the error rate and to a better use of the warehouse capacities.

decrees by the Ministry of Health of the Czech Republic and the State Institute for Pharmaceutical Control. The company is inspected by the responsible state authorities - Czech Agricultural and Food Inspection and State Institute for Pharmaceutical Control.

Hazard Analysis Critical Control Points (HACCP) In the area of the manufacture of nutritional supplements the company applies a quality management system in compliance with the system of critical points required for the manufacture of food. This system analyses risks, critical steps and processes during the manufacturing process that could influence the quality of the product and determines the corrective measures so that the products are not a health risky.

Good Manufacturing Practice (GMP) This concerns a wide range of requirements that are stricter than the legislative requirements for the manufacture of food.

Good Manufacturing Practice is required by legislation during the manufacture of pharmaceuticals; the recommended GMP procedures are also applied at the Pharmaceutical Division during the manufacture of nutritional supplements.

18

Walmar k

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

19

Socially responsible company

Socially responsible company The company Walmark ranks among prominent donators in the region of North Moravia. In 2005 Walmark extended its donor activities by the first nationwide CSR (Corporate Social Responsibility) project the Company Friendly to All Generations (SPVG). The present-day Czech society is growing old considerably. According to the demographic development the percentage of elderly citizens will rise distinctively within the following 20 years. The sociological research signals the fact

Mission and vision for the future

that a number of false opinion stereotypes as well as misconceptions spin around old age. The cases of direct or indirect discrimination on the basis of age – ageism reflect the present reality.

The project the Society Friendly to All Generations and its partner the Diacony of the Evangelical Church of the Czech Brethren, which cares for 4000 seniors, actively stand out against the unfavourable image of old age and support activities developing all essential parts of fully-fledged life in old age. These are mainly an active preparation for one’s old age and eliminating of the most visible problems within the traditionally complex intergenerational dialogue. The principal intention of this project is enlightenment of the old age issue with the aim to start a wide all-society discussion about the position of

Mission and vision for the future

seniors and the support of the intergenerational understanding.

Walmark is aware of the obligation towards society, connected with insisting upon our principles of responsibility for health and a healthy lifestyle. The company’s mission is to provide innovative top-quality products and services in the area of health care, to promote healthy lifestyle in an active way and to lead our clients to responsible approach to their own health which is the basic prerequisite of a full-valued and active life.

The mission has to be fulfilled in all countries where Walmark is active in, as a socially responsible company by observing particularly principles like reaching prosperity in a fair and ethical way, aiming in particular at the clients in order to understand and satisfy their needs by best-quality modern products, innovating and developing products according to latest findings of science and research, looking for new ideas and directions, maintaining transparent and fair relationship with all business partners, etc.

The company’s target and vision to the future is to establish a strong Central European company with the ambition of further expanding on world markets in the segment of nutritional supplements and pharmaceutics by increasing the market value and maintaining stabile grow and moreover to continue to seek, analyse and subsequently invest into new areas, which promise an appropriate profit and growth potential.

The company Walmark has recently defined the long-term targets for the future period. The main goal is to become one of the three biggest producers of nutritional supplements in Europe by the year 2012 and to become the market leader by the year 2017. Supplementary goal is to become the biggest company in Central Europe in the segment of sports nutrition by the year 2012. With the regards to medicines, Walmark is aiming to increase the share of sales of medicinal products (Rx & OTC) in Czech Republic, Slovakia, Poland, Hungary and Romania for at least 10% of the total sales by the year 2012.

20

Walmar k

C O M P A N Y P R E S E N TA T I O N 2 0 0 8

21

Contact data

Contact data WALMARK, a.s.

UAB „Walmark“

Oldřichovice 44

Ateities str. 10

739 61 Třinec

LT – 08303 Vilnius

Czech Republic

Lithuania

Phone number: +420 558 301 211

Phone number: +370 5 210 19 40

Fax number: +420 558 301 311

Fax number: +370 5 272 07 43

E-mail: info@walmark.cz

E-mail: info@walmark.lt

www.walmark.cz

www.walmark.lt

Director: Oto Toman

Director: František Čekal

WALMARK, spol. s r.o.

SIA „Walmark“

Na stanicu 22

Zemitanu Str. 2b

010 09 Žilina

LV-1012 Riga

Slovakia

Latvia

Phone number: +421 41 5053 111

Phone number: +371 671 86752

Fax number: +421 41 5053 112

Fax number: +371 671 86753

E-mail: walmark@walmark.sk

E-mail address: info@walmark.lv

www.walmark.sk

www.walmark.lv WALMARK Romania, S.R.L.

Director: Radim Mládenek

Director: František Čekal

Strada Fecioarei nr 7, sector 2, 020104 Bucharest Romania

WALMARK, Sp. z o.o.

Phone number: +40 21 212 27 24

ul. Teatralna 9 41-200 Sosnowiec

Fax number: +40 21 210 77 64 E-mail: info@walmark.ro

Poland Phone number: +48 32 294 94 58 Fax number: +48 32 293 45 74

www.walmark.ro Director: MUDr. Horia Vilcu

E-mail: info@walmark.pl

Oldřichovice 44 739 61 Třinec Czech Republic Phone number: +420 558 301 348 Fax number: +420 558 301 366 E-mail: export@walmark.cz

www.walmark.pl Director: Zbigniew Pytlik, M.Sc.Econ., MBA

WALMARK, a.s. – Export Department

www.walmark.biz Walmark Bulgaria, S.R.L.

Director: Dimitris Anestis

70 Tsaribrodska Str., floor 4, Office 7, WALMARK Kft.

1309 Sofia

Gyógyszer részleg

Bulgaria

3526 Miskolc Blaskovics u. 1.

Hungary Phone number: +36 46 507 770 Fax number: +36 46 507 771

Phone number: + 359 2 920 90 65 Fax number: + 359 2 920 90 45 E-mail: info@walmark.bg www.walmark.bg Director: Eugen Antohi

E-mail: info@walmark.hu www.walmark.hu Director: Beáta Voláková

Walmark, o.o.o.

Geroev Kosmosa 4 03 680 Kiev Ukraine Phone number: +38 44 499 14 50 (51, 52) Fax number: +38 44 490 98 29 E-mail: info@walmark.ua www.walmark.ua Director: Eugen Antohi

22

Walmar k

C O M P A N Y P R E S E N TA TAT TION 2008

23

WALMARK • HEALTH FOR THE WHOLE FAMILY

Walmark, a.s.

Oldřichovice 44 739 61 Třinec Czech Republic

Tel.: +420 558 301 348 Fax: +420 558 301 366 e-mail: export@walmark.cz www.walmark.biz